Regulatory Intelligence Automation – A Challenging Endeavor
Managing regulatory intelligence information and delivering the broad variety of services expected of regulatory intelligence departments continues to be a challenge for the biopharmaceutical industry. The Gens & Associates 2022 Regulatory Intelligence Industry Survey (n = 42) identified the degree of technology support for ten specific use cases. The survey also explored the level of automation being applied to core activities carried out in regulatory intelligence programs.